Utilization of plasma and urine methadone concentrations to optimize treatment in maintenance clinics: I. Measurement techniques for a clinical setting
- PMID:8018740
- DOI: 10.1300/J069v13n01_02
Utilization of plasma and urine methadone concentrations to optimize treatment in maintenance clinics: I. Measurement techniques for a clinical setting
Abstract
One difficulty for methadone maintenance treatment programs is the absence of a simple, analytical method useful for guiding adjustment of methadone dose. Currently, dose adjustment decisions are based upon: documentation of continuing opioid use by qualitative urine drug screens, patient complaints of dose not holding or physiological evidence of opioid withdrawal. Although decisions utilizing clinical parameters are helpful in adjustment of dose, a sizeable number of patients continue to receive inadequate doses. Incorrectly, many clinicians assume that low doses prevent toxicity and favor eventual abstinence. One solution to the question of efficacious dose adjustment would be utilization of repetitive blood sampling for monitoring plasma methadone concentrations to insure they remain within established therapeutic windows. Unfortunately, it is impractical to obtain ongoing blood samples from these patients because of poor venous access and the unpleasantness of frequent phlebotomy. To circumvent these problems, we developed analytical methods useful for estimating plasma methadone concentrations from random, spot urine samples. Over the past several years, we have analyzed approximately 16,000 samples (urine plus plasma) drawn from 200 methadone maintenance patients. These data have allowed generation of methadone dose vs. plasma methadone concentration curves, demonstrating why dose adjustment decisions should be buttressed with objective laboratory data. In addition, these methods are useful for uncovering covert methadone supplementation and diversion. These improvements in clinical care have been accomplished using a computerized, pharmacokinetics program which accounts for compounding effects of urine pH, specific gravity, volume of distribution and gender upon renal methadone excretion. The program allows calculation of total plasma methadone concentrations from concurrent urine measurements, which are within 5-10% of actually measured values. This system has eliminated the need for venous blood sampling, resulted in optimization of patient doses and helped uncover supplementing or diverting of methadone.
Comment in
- Methadone maintenance: optimizing dosage by estimating plasma level.Dole VP.Dole VP.J Addict Dis. 1994;13(1):1-4. doi: 10.1300/J069v13n01_01.J Addict Dis. 1994.PMID:8018735No abstract available.
Similar articles
- Utilization of plasma and urine methadone concentration measurements to limit narcotics use in methadone maintenance patients: II. Generation of plasma concentration response curves.Kell MJ.Kell MJ.J Addict Dis. 1995;14(1):85-108. doi: 10.1300/J069v14n01_09.J Addict Dis. 1995.PMID:7632750
- The use of levo-alpha-acetylmethadol (LAAM) in methadone patients who have not achieved heroin abstinence.Borg L, Ho A, Wells A, Joseph H, Appel P, Moody D, Kreek MJ.Borg L, et al.J Addict Dis. 2002;21(3):13-22. doi: 10.1300/J069v21n03_02.J Addict Dis. 2002.PMID:12094997
- Cocaine abuse in methadone maintenance patients is associated with low serum methadone concentrations.Tennant F, Shannon J.Tennant F, et al.J Addict Dis. 1995;14(1):67-74. doi: 10.1300/J069v14n01_07.J Addict Dis. 1995.PMID:7632748
- Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.Pergolizzi J, et al.Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.Pain Pract. 2008.PMID:18503626
- When "enough" is not enough: new perspectives on optimal methadone maintenance dose.Leavitt SB, Shinderman M, Maxwell S, Eap CB, Paris P.Leavitt SB, et al.Mt Sinai J Med. 2000 Oct-Nov;67(5-6):404-11.Mt Sinai J Med. 2000.PMID:11064491Review.
Cited by
- Better retention of Malaysian opiate dependents treated with high dose methadone in methadone maintenance therapy.Mohamad N, Bakar NH, Musa N, Talib N, Ismail R.Mohamad N, et al.Harm Reduct J. 2010 Dec 17;7:30. doi: 10.1186/1477-7517-7-30.Harm Reduct J. 2010.PMID:21167035Free PMC article.
- Methadone Concentrations in Exhaled Breath Condensate, Serum and Urine of Patients Under Maintenance Treatment.Khoubnasabjafari M, Ansarin K, Jouyban-Gharamaleki V, Panahi-Azar V, Hamidi S, Azarmir Z, Jouyban A.Khoubnasabjafari M, et al.Iran J Pharm Res. 2017 Fall;16(4):1621-1630.Iran J Pharm Res. 2017.PMID:29552071Free PMC article.
- Glucuronidation of 3'-azido-3'-deoxythymidine (zidovudine) by human liver microsomes: relevance to clinical pharmacokinetic interactions with atovaquone, fluconazole, methadone, and valproic acid.Trapnell CB, Klecker RW, Jamis-Dow C, Collins JM.Trapnell CB, et al.Antimicrob Agents Chemother. 1998 Jul;42(7):1592-6. doi: 10.1128/AAC.42.7.1592.Antimicrob Agents Chemother. 1998.PMID:9660989Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous